evotec.com (EVO): Net earnings per share for the last 12 months

EVO (Evotec AG) - company brandmark

Evotec SE is developing a unique CRO platform by sharing risks and profits with its partners. Long-term contracts ensure a stable cash flow, while the recruitment of bioanalytics experts strengthens its scientific potential. This 12-month net income per share chart provided by GURU.Markets helps filter out market noise, while -0.59 shapes the current metric.

EVO Evotec Group Net earnings per share for the last four quarters (07/04/2022 - 11/15/2026)

Evotec Group - analytical breakdowns and key metrics (EVO)

- current quotes and average value forecast:
Price Chart Evotec AG|EVO - Analyst Median Target
- stock exchange capitalization data:
Market Valuation Evotec SE|EVO - Aggregate Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Evotec|EVO - Book Valuation of Business|Market Capitalization to Book Value Ratio evotec.com|EVO - Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Evotec SE|EVO - Long-Term Debt to Equity|Short-Term Debt to Equity Evotec AG|EVO - Company Cumulative Debt|Debt to Book Value Evotec SE|EVO - Amount of Long-Term Liabilities|Company Short-Term Debts Evotec|Quick Ratio evotec.com
- earnings and multiples data:
EVO - Net Income|Future Profit Evotec SE|EVO - Company Value to Net Income|Future Price to Earnings Evotec Group|EVO - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Evotec SE|EVO - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Evotec|EVO - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months evotec.com|EVO - Earnings per share growth in current year|Net earnings per share growth forecast for next year Evotec SE
- total revenue and sales volume data:
EVO - Company Total Revenue|Company Projected Revenue Evotec SE|EVO - Price-to-Sales Ratio|Forward P/S Multiple Evotec Group
Basic company analysis:Evotec SE - EVO
Flagship merchandise of Evotec Corp

Evotec SE (EVO) expansion into the AI development and Just-Evotec biologics segment is creating long-term B2B streams that convert directly into final business profitability. This rolling annual earnings per share measures net income distributed across the total share issuance, allowing investors to assess real capital efficiency net of borrowing costs and operating expenses.

Who Evotec SE competes with

IQV - Earnings per share for the last twelve months|Labcorp Holdings - Earnings per share for the last four quarters|Medpace Corp (MEDP) - Earnings per share for the last twelve months|ICLR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months criver.com|FTRE (fortrea.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Lifecore (LFCR)|Net earnings per share for the last four quarters OmniAb Inc.|Net earnings per share (EPS TTM) NOTV (Inotiv Corporation)|Net earnings per share (EPS TTM) Avid Bioservices, Inc. CDMO|Catalent, Inc - Net earnings per share (EPS TTM)|nighthawkbio.com (SCPX) - Net earnings per share for the last 12 months